House Subcommittee Approves $2.1 Billion for FDA - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

House Subcommittee Approves $2.1 Billion for FDA


ePT--the Electronic Newsletter of Pharmaceutical Technology

Washington, DC (June 26)—The US Food and Drug Administration will have a $2.1 billion budget next year if the fiscal year 2009 bill markup by the US House of Representatives’ Agriculture Appropriations Subcommittee passes through Congress. The subcommittee approved for FDA $282 million above the President’s budget request for FY 2009.

In her opening statement at last week’s meeting, Subcommittee Chairwoman Rosa DeLauro (D-CT) noted that the administration had recently made a request for an additional $275 million for FDA [see full story]. “To be sure, this is a long overdue acknowledgment that the status quo is not working when it comes to our broken food safety system,” she said. “So we are indeed, eager to fully fund that request and provide the critical resources necessary for reform.”

DeLauro added her concern that the administration has yet to indicate how FDA should use these additional funds. “…Real reform requires real management – so this committee will convene hearings and require spending reports to ensure the money is used as effectively as possible,” she said.

The marked-up Subcommittee bill goes to the House Appropriations Committee next where it will be further reviewed and marked up before going to the full House of Representatives.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here